Localization, quantification, and activation of platelet-activating factor receptor in human endometrium during the menstrual cycle: PAF stimulates NO, VEGF, and FAK(pp125)

FASEB Journal

Volumn 12, Issue 10, 1998, Pages 831-843

  Ahmed, Asif ^a   Dearn, Sharon ^a   Shams, Munjiba ^a   Li, Xiao F ^a   Sangha, Rajbant K ^a   Rola Pleszczynski, Marek ^b   Jiang, Jianqiao ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Implantation; Menstruation; Nitric oxide; PAF receptor; Uterus

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; FOCAL ADHESION KINASE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; VASCULOTROPIN;

ARTICLE; BLASTOCYST; BLOOD VESSEL PERMEABILITY; ENDOMETRIUM; EXTRACELLULAR SPACE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MENSTRUAL CYCLE; NIDATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERUS; VASODILATATION;

EID: 0031750585     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.12.10.831     Document Type: Article

References (38)

1. McRae, A. C., and Heap, R. B. (1988) Uterine vascular permeability, blood flow and extra cellular fluid space during implantation in rats. J. Reprod. Fertil, 82, 617-625
2. Ahmed, A., and Dcurn, S. (1997) The role of platelet-activating factor and its receptor in endometrial receptivity. Adv. Exp. Med. Biol. 416, 277-290
3. Alecozay, A. A., Harper, M. J. K., Schenken, R. S., and Hanahan, D.J. (1991) Paracrine interaction between platelet-activatingfac- tor ana prostagiandins in hormonally-treated human luteal phase enomuintriuium In vitro.J. Reprod. Fertil. 91, 301-312
4. 2 by separated cells of human cndometrium.J. Reprod. Fertil. 82, 271-276
5. Spinks, N. R., Ryan, J. P., and O'Neill, C. (1990) Antagpnists of embryo-derived platelet-activating factor act by inhibiting the ability of the mouse ernbryp to Epiant. J. Reprod. Fertil. 88, 241-248
6. Nakamura, M., Honda, Z., Izumi, T., Sakanaka, C., Mutoh, H., Minami, M., Bito, H., Scyama, Y., Matsumoto,T., Norna, M:,and Shimizu.T. (1991) Molecular cloning and expression of plateletactivating factor receptor from human leukocytes.J. Biol. Chem. 266, 20400-20405
7. Seytned, C. E., Schweickarti V. L., Gpdiska V. L. R., and Gray, P. W. (1992) The human platelet-activating Factor receptor gene (PTAFR) contains no introns and maps to chrosome 1. Genomics 13, 832-834
8. Mutoh, H., Bito, H., Minami, M., Nakamura, M., Honda, A., Izumi, T., Nakata, R., Kurachi, Y., Tcrano, A., and Shimizu, T. (1993) Two different promoters direct expression of two distinct forms of mRNA of human receptor from human leukocytes. FEBS Lett. 322, 129-134
9. Kudolo, G. B., Kasamo, M., and Harper, M.J. K. (1991) Auto radiographie localisation of platelet-activating factor (PAF) binding sites in the rabbit endometrium during the peri-implantation period. Cell Tissue Res. 265, 231-241
10. Ahmed, A., Sage, S. O., Plevin, R., Shoaibi, M. A., Sharkey, A. M., and Smith, S. K. (1994) Functional platelet-activating factor receptors linked to inositol lipid hydrolysis, calcium mobilisation and ryrosine kinase activity in the human endometrial HEC-1B cell line.J. Reprod. Fertil. 101, 459-466
11. Ahmed, A., and Smith, S.K. (1992) Platelet activating factor stimulates phospholipase C activity in human endometrium. J. Cell. Physiol. 152, 207-214
12. Ahmed, A., Ferriani, R. A., Plevin, R., and Smith, S. K. (1992) Platelet-activating factor mediates phosphatidylcholine hydrolysis by phospholipase D in human endometrium. Biol. Reprod, 47, 59-65
13. Ahmed, A., Plevin, R., and Smith, S. K. (1995) Oestradiol-17β modulates PAF-evoked phospholipase D activity but not inositol lipid hydrolysis in human endometrial cell line, HFC-1B. Cell. Signal. 7, 1-7
14. Lowenstein, C. J., Dinerman, J. L., and Snyder, S. H. (1994) Nitric oxide: a physiologic messenger. Ann. Int. Med.. 120, 227-233
15. Fox, H., and Buckley, C. H. (1983) Endometrium. In Atlas of Gynaecological Pathology (Gresham, G. A., ed) pp. 61-63, MTP Press Ltd., London
16. Ahmed, A., Li, X. F., Shams, M., Gregory, J., Rollason, T., Barnes, N. M., and Newton, J. R. (1995) Localization of the angiotensin. II and its receptor subtype expression in human cndometrium and identification of a novel high-affinity angiotensin II binding site.J. Clin. Invest. 96, 848-857
17. Müller, E., Dagenais, P., Alami, N., and Rola-Pleszxzynski, M. (1993) Identification and functional characterization of plateletactivating factor receptors in human leukocyte populations using polyclonal anti-peptide, antibody. Proc, Natl. Acad. Sci. USA 90, 5818-5822
18. Shams, M., and Ahmed, A. (1994) Localisation of mRNA for basic fibroblast growth factor in human placenta. Growth Factors 11, 105-111
19. Sangha, R. K., Li, X.-F., Shams, M., and Ahmed, A. (1997) FGF Receptor-1 (fig) is a critical component for endometrial remodelling; Localisation and expression of FGF-2 and FGF-R1 in human endometrium during the menstrual cycle and decreased FGF-R1 expression in menoirhagia. Lab. Invest. 77, 389-402
20. Heuer, H. O., Casals-Stenzel, J., Muacevic, G., and Weber, K. H. (1990. Pharmacologie activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet-activating factor. J. Pharmacol. Exp. Tim. 255, 962
21. Ahmed, A., Dunk, C., Kniss, D., and Wilkes, M. (1997) Role of VEGF receptor (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. Lab. Invest. 76, 779-791
22. 2+ signaling and mRNA expression of platelet-activating factor receptor by estradiol in human uterine endometrial cells. Adv. Exp. Med. Biol. 416, 95-100
23. Mutoli, H., Kume, K., Sato, S., Kalo, S., and Shimizu. T. (1994) Positive and negative regulations of human platelet-activating factor receptor transcript 2 (tissue-type) by estrogen and TGF-beta 1. Biochm. Biophys, Res. Commun. 205, 1130-1136
24. Charnock-Jones, D. S., Sharkey, A., Rajput-Williams, L., Burch, D., Schofield, J. P., Fountain, S. A., Boocock, C. A., and Smith, S. K. (1993) Identification and localisation of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol. Reprod. 48, 1120-1128
25. Li, X. F., Gregory, J., and Ahmed, A. (1994) Imnumolocalisation of vascular endothelial growth factor in human endometrium. Growth factors 11, 277-282
26. Shams, M., Sisi, aP., and Ahmed, A. (1996) Localisation of bradykinin type II receptor mRMA in human endometrium. Mol. Human Reprod, 2, 35-39
27. Kamata, K., Mori, T., Shigenobu, K., and Kasuya, Y. (1989) En-dothelium-dependent vasodilator effects of platelet-activating factor on rat resistance vessels. Br. J. Pharmacol. 98, 360-364
28. Juncos, L. A., Ren, Y., Arima, S., and Ito, S. (1993) Vasodilator and constrictor actions of platelet-activating factor in the isolated microperfused afferent arteriole of the rabbit kidney. Role of endothelium-derived relaxing factor/NO and cyclooxygenase products.J. clin. Invest. 91, 1374-1379
29. Wilkinson S. E., Parker, P. J., and Nixon, J. S. (1993) Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochm J. 294, 335-337
30. Dearn, S., and Ahmed, A. (1998) Activation of platelet-activating factor receptor stimulates nitric oxide release in human endometrial epithelial cell line (HEC-1B) via protein kinase C alpha. Lab. Invest. In press
31. Chaudhuri, G., and Nathan, L. (1992) Nitric oxide and eadometrial blood flow. In Steroid Hormones and Uterine Bleeding (Alexander, N.J., and d'Ananguus, C., eds) pp. 241-244, AAAS Publication, Washington, D.G.
32. Guyton, A. C. (1981) Textbook of Medical Physiology, pp. 1005-1020, W. B. Saunders, Philadelphia
33. Camussi, C., Montrucchio, G., Lupia, E., De Martino, A., Perona, L., Arese, M., Vercellone, A., Toniolo, A., and Bussolino, F. (1995) Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism.J. Immunol. 154, 6492-501
34. Bussolino, F., Camussi, G., Aglietta, M., Braquet, M., Bosia, P., Pescarmona, G., Sanavio, F., D'Urso, M., and Marchisio, M. (1987) Human endothelial cells are targets for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeletal structure and promotes albumin diffusion across endothelial monolayer.J. Immunol. 139, 2439-2446
35. Camussi, G., Turello, E., Bussolino, F., and Baglioni, C. (1991) Tumour necrosis factor alters cytoskeletal organization and barrier function of endothelial cells. Int. Arch. Allergy Appl. Immunol. 96, 84
36. Montrucchio, G., Lupia, E., Battaglia, E., Passerini, G., Bussolino, F., Emanuelli, G., and Camussi, G. (1904) Tumour necrosis factor alpha-induced angiogenesis depends on in situ platelet-acti-vating factor biosynthesis.J. Exp. Med. 180, 377-382
37. Bussolino, F., Arese, M., Montrucchio, G., Primo, L., Benelli, R., Sanavio, F., Aglietta, M., Ghigo, D., Rola-Pleszczynski, M., Bosia, A., Albini, A., and Camussi, G. (1995) Platelet-activating factor produces in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis.J. Clin. Invest. 96, 940-952
38. Shweiki, D., Itan, A., Soffer, D., and Keshet, E. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hy-poxias-initiated angiogenesis. Nature (London) 359, 843-845